NANO-OJAS Trademark
Trademark Overview
On Thursday, June 16, 2016, a trademark application was filed for NANO-OJAS with the United States Patent and Trademark Office. The USPTO has given the NANO-OJAS trademark a serial number of 87073835. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, June 27, 2026. This trademark is owned by NANORX INC.. The NANO-OJAS trademark is filed in the Pharmaceutical Products category with the following description:
Analgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-v...
General Information
| Serial Number | 87073835 |
| Word Mark | NANO-OJAS |
| Filing Date | Thursday, June 16, 2016 |
| Status | 800 - REGISTERED AND RENEWED |
| Status Date | Saturday, June 27, 2026 |
| Registration Number | 5105133 |
| Registration Date | Tuesday, December 20, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 4, 2016 |
Trademark Statements
| Goods and Services | Analgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Nutraceutical preparations for the treatment of inflammatory disorders; Nutraceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Nutraceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Nutraceutical preparations for the prevention of diabetes; Nutraceutical preparations for the treatment of eye diseases and conditions; Nutraceutical preparations for the treatment of heart rhythm disorders; Nutraceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Nutraceutical preparations for the treatment of infectious diseases; Nutraceutical preparations for the treatment of hypertension; Nutraceutical preparations for treating allergic rhinitis and asthma; Nutraceutical preparations for treating diabetes; Nutraceutical preparations for treating skin disorders; Nutraceutical preparations for use in urology; Nutraceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Nutraceutical products for ophthalmological use; Nutraceutical products for the treatment of bone diseases; Nutraceutical products for the treatment of joint disease; Nutraceutical products for the treatment of viral and infectious diseases; Nutraceutical preparations for the treatment of cancer; Nutraceutical products for treating respiratory diseases and asthma; Nutraceutical solutions used in dialysis; Nutraceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and nutraceutical purposes; Therapeutic nutraceuticals for the treatment of obesity |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 22, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, May 21, 2014 |
| First Use In Commerce Date | Wednesday, May 21, 2014 |
Trademark Owner History
| Party Name | NANORX INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Chappaqua, NY 10514
US |
| Party Name | NANORX INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Chappaqua, NY 10514
US |
| Party Name | NANORX INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chappaqua, NY 10514
US |
Trademark Events
| Event Date | Event Description |
| Monday, June 20, 2016 | NEW APPLICATION ENTERED |
| Wednesday, June 22, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 15, 2016 | ASSIGNED TO EXAMINER |
| Monday, August 15, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 15, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 15, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 15, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 15, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 30, 2016 | ASSIGNED TO LIE |
| Tuesday, August 30, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, September 14, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 15, 2016 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, September 27, 2016 | ASSIGNED TO PETITION STAFF |
| Tuesday, October 4, 2016 | ASSIGNED TO EXAMINER |
| Tuesday, October 4, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 4, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, October 5, 2016 | POST PUBLICATION AMENDMENT - ENTERED |
| Tuesday, December 20, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Monday, December 20, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, November 3, 2022 | TEAS SECTION 8 & 15 RECEIVED |
| Thursday, May 18, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, May 18, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, May 18, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Saturday, December 20, 2025 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Monday, April 27, 2026 | TEAS SECTION 8 & 9 RECEIVED |
| Saturday, June 27, 2026 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Saturday, June 27, 2026 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Saturday, June 27, 2026 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Saturday, June 27, 2026 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
